OPRE Evaluation - National and Tribal Evaluation of the 2nd Generation of the Health Profession Opportunity Grants [descriptive evaluation, impact evaluation, cost-benefit analysis study, pilot study]
ICR 202112-0970-002 · OMB 0970-0462 · Received in OIRA
⚠️ Notice: This information collection may be outdated. More recent filings for OMB 0970-0462 can be found here:
OPRE Evaluation - National and Tribal Evaluation of the 2nd Generation of the Health Profession Opportunity Grants [descriptive evaluation, impact evaluation, cost-benefit analysis study, pilot study]
No material or nonsubstantive change to a currently approved collection
No
Regular
12/07/2021
table that charts list comparision
Requested
Previously Approved
07/31/2024
07/31/2024
7,298
7,298
2,977
2,977
0
0
Between August 2015 and July 2019, OMB has approved several information collection instruments, procedures and supporting materials in support of the HPOG 2.0 National and Tribal Evaluation. These include baseline data collection from all study participants, data collection protocols and procedures for the HPOG 2.0 Tribal Evaluation, and several instruments in support of the National Evaluation, including Short-Term and Intermediate Follow-up Surveys to support the HPOG 2.0 National Evaluation impact study. In July 2021, OMB approved Instrument 12a COVID-Cohort Short-term Survey (COVID-19 Cohort STS) and supporting materials.
Since approval, the following events have led to the need for minor changes so some of the currently approved information collection.
⢠OPREâs Privacy Analyst reviewed the advance letter (Attachment K) and requested changes. An updated Attachment K is included with this request.
⢠While preparing to program the COVID-19 Cohort STS (Instrument 12a), the team identified revisions to language that would help with the clarity of the request. The team also had a change in staffing resulting in a necessary update to contact information. An updated Instrument 12a is included with this request.
⢠The success of the Intermediate Follow-up Survey Critical Items Only (Instrument 18a)âwhich was still underway at the time the COVID-19 Cohort STS was submitted to OMB for review and approval â led the team to create a similar Critical Items Instrument for the COVID-19 Cohort STS. This Critical Items Survey is labeled as Instrument 12b and is included with this request.
The original burden estimate for Instrument 12a, the COVID-19 Cohort STS, was based on a presumed sample size of 7,500 study participants, a 75 percent response rate (5,625 responses), and a 60-minute length. The revised burden estimates reflect the same total number of responses (5,625), however, the overall response rate allows for 518 interviews to be completed using the shorter, critical items version of the COVID-19 Cohort STS (Instrument 12b). The shorter interview, the subject of this nonsubstantive change request, is estimated at just 20 minutes. The requested change reduces the original burden estimate for COVID-19 Cohort STS from 1,875 hours annually to 1,851 hours annually, a burden reduction of 6.2 percent annually. Burden estimates were reduced to 0 for Instrument 1 (PAGES Participant-level baseline data collection, tribal and non-tribal grantees) and for Instruments 18 and 18a now that the study enrollment and the Intermediate Follow-up survey data collection are complete.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Instrument 12b: HPOG 2.0 National Evaluation Intermediate Follow-up COVID-19 Cohort Short-term Survey – Critical Items Only